ライフサイエンスコーパス: psychotropic drug

1 77 [95% CI, 1.72 to 4.44] for treatment with psychotropic drugs).

2 ad substitution of antipsychotics with other psychotropic drugs.

3 peutic actions as well as adverse effects of psychotropic drugs.

4 ar dysrhythmias in pediatric patients taking psychotropic drugs.

5 chiatric patients and the effects of various psychotropic drugs.

6 rcent of the patients were also treated with psychotropic drugs.

7 ents with current insomnia, 28% received any psychotropic drug; 14% received benzodiazepines and 19%

8 Psychotropic drugs, 5-hydroxytryptamine (5-HT)-receptor

9 nes may influence phenotypes associated with psychotropic drug administration.

10 hildren with OCD who had not been exposed to psychotropic drugs, aged 7 to 18 years, and 19 case-matc

11 e intracellular chaperone proteins that bind psychotropic drugs and also clinically used drugs such a

12 that the negative association between use of psychotropic drugs and MMSE score (p = 0.004) is particu

13 ard and dependence, brain trauma and injury, psychotropic drugs and pain using small animals.

14 of therapies should be used, and the use of psychotropic drugs and psychological treatment alternati

15 ectrocardiogram in pediatric patients taking psychotropic drugs and recommendations for monitoring th

16 widely; they bind diverse ligands, including psychotropic drugs and steroids, regulate many ion chann

17 ng in zebrafish to discover and characterize psychotropic drugs and to dissect the pharmacology of co

18 t seen after chronic administration of other psychotropic drugs and was not observed for JAK1.

19 Treatment patterns for psychotropic drugs appear to have remained stable over t

20 pensity substantially increase when specific psychotropic drugs are administered to patients with hyp

21 chronic administration of nonantidepressant psychotropic drugs (cocaine or haloperidol), demonstrati

22 Psychotropic drug costs increased during the first year

23 administration of several nonantidepressant psychotropic drugs did not influence expression of CREB

24 the potentially confounding effects of prior psychotropic drug exposure.

25 hat bind certain steroids, neuroleptics, and psychotropic drugs, form a trimeric complex with ankyrin

26 e, and stress, repeated treatment with other psychotropic drugs (haloperidol, raclopride, sertraline,

27 The authors examined how the use of psychotropic drugs has shifted over the course of 10 yea

28 Many specific psychotropic drugs have been reported to prolong the QTc

29 Therapeutic outcomes from several psychotropic drugs have been weakly linked to specific g

30 death in pediatric patients taking selected psychotropic drugs have raised the possibility of ventri

31 had not received any sedation, narcotic, or psychotropic drug in the previous 24 hrs.

32 The use of psychotropic drugs in clinical and translational brain r

33 city that underlies the long-term actions of psychotropic drugs in the brain.

34 The use of psychotropic drugs in the pediatric population has incre

35 Exposure to certain psychotropic drugs in utero may increase the risk for so

36 yping and screening of genetic mutations and psychotropic drugs in zebrafish (Danio rerio).

37 g-term adaptations underlying the effects of psychotropic drugs, including the actions of antidepress

38 to help understand the long-term effects of psychotropic drugs, including the latency in onset of th

39 ripheral OE can serve as a proxy for certain psychotropic drug-induced actions on SVZ brain cell prol

40 These results show that psychotropic drug-induced cell proliferation occurs in t

41 Many psychotropic drugs interfere with the reuptake of dopami

42 -HT(2C) receptors in motivated behaviors and psychotropic drug mechanisms.

43 , address this question and demonstrate that psychotropic drugs modify specific methyl-CpG-binding pr

44 sonance imaging studies were conducted in 21 psychotropic drug-naive children, aged 8 to 17 years, wi

45 n severity on the CY-BOCS in the subgroup of psychotropic drug-naive patients.

46 MRI examinations of 37 psychotropic drug-naive pediatric OCD patients and 26 ag

47 ous 1.5-mm magnetic resonance images from 23 psychotropic drug-naive pediatric patients with OCD (sev

48 ry to examine brain structure, especially in psychotropic drug-naive pediatric patients.

49 -blind, placebo-controlled trial (Effects of Psychotropic Drugs on Developing Brain-Methylphenidate)

50 e of cimetidine (OR 2.5, 95% CI 1.4-4.6) and psychotropic drugs (OR 2.2, 95% CI 1.4-3.3).

51 re (OR, 4.99; 95% CI, 1.16 to 21.38) or with psychotropic drugs (OR, 2.78; 95% CI, 1.10 to 7.01).

52 Surprisingly, another psychotropic drug, phencyclidine, displayed a selective

53 Using this approach, we identified the psychotropic drug pimozide as a STAT5 inhibitor.

54 ls for understanding the mechanisms by which psychotropic drugs produce long-lived alterations in bra

55 ent with lamotrigine was initiated and other psychotropic drug regimens were discontinued, patients w

56 pect of identifying biological predictors of psychotropic drug response and could provide the means o

57 nitial research into the pharmacogenetics of psychotropic drug response suggests that specific genes

58 rst generation of pharmacogenetic studies of psychotropic drug response, and consider future directio

59 el method of dissecting the heterogeneity of psychotropic drug response.

60 ric conditions, and concomitant use of other psychotropic drugs, risk of suicide death was 2.7 times

61 tric outpatients taking weight gain-inducing psychotropic drugs (sample 1, n = 152).

62 Under the influence of commonly used psychotropic drugs, some acutely ill, hospitalized patie

63 cognition, and addiction and is regulated by psychotropic drugs, stress, and corticosteroids.

64 ch more likely to receive a variety of other psychotropic drugs than nonusers of the same sex and age

65 t mediates the modulation of ion channels by psychotropic drugs through a unique transduction mechani

66 rovides a mechanism of adaptation to chronic psychotropic drug treatment.

67 ncluding chronic electroconvulsive seizures, psychotropic drug treatments, and lesions.

68 Although sex differences occur with some psychotropic drug treatments, they are not well defined

69 bid personality disorder (1.24 [1.11-1.39]), psychotropic drug use (antipsychotics 1.51 [1.35-1.69],

70 uthors present disorder-based guidelines for psychotropic drug use during pregnancy and for psychiatr

71 rmed to review information on the effects of psychotropic drug use during pregnancy on fetal outcome.

72 Psychotropic drug use was lower among African Americans

73 l need (as measured by prior service use and psychotropic drug use).

74 parents' report of neurologic complications, psychotropic drug use, and special education.

75 nmental and personal safety, wheelchair use, psychotropic drug use, and transferring and ambulation.

76 Use of psychotropic drugs, use of mental health services, and d

77 rgest category, decreased as a proportion of psychotropic drug visits (P< or =.01) and are now surpas

78 atient care was 4.2%, and for treatment with psychotropic drugs was 32.3%.

79 protein (CREB) in the adaptive responses to psychotropic drugs, we have developed inducible, brain r

80 The major classes of psychotropic drugs were introduced in an extraordinary d